The University of Hong Kong: Schizophrenia trials
The registry lists 13 Schizophrenia studies with The University of Hong Kong as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 3Phase 3 2Phase 4 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and RelapseRecruitingNCT07616999
- Real-life Assessment of Abilify Maintena + Rexult in SchizophreniaCompletedNCT05169268
- Mindfulness Intervention and Relapse in PsychosisCompletedNCT04060498Not applicable
- Exercise and Overnight Motor Sequence TaskCompletedNCT03800368Not applicable
- Early Detection and Intervention for Women At-risk of PsychosisStatus unknownNCT03751865Not applicable
- Substance Misuse To Psychosis for StimulantsCompletedNCT03485417Phase 2/3
- Substance Misuse To Psychosis for Ketamine (SToP-K)CompletedNCT03485339
- Berberine as Adjuvant Treatment for Schizophrenia PatientsCompletedNCT02983188Phase 2/3
- The Two-Way Communication Checklist (2-COM) in First Episode Psychosis Patients in Hong KongCompletedNCT02435784Not applicable
- Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With SchizophreniaCompletedNCT01852331Phase 2
- Coaching Intervention for Patients With Early PsychosisStatus unknownNCT01792856Not applicable
- Glucose as a Mediator of Self-control Performances in Patients With SchizophreniaStatus unknownNCT01563016Not applicable
- Antipsychotic Therapy and First EpisodeCompletedNCT00334035Phase 4